Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

The role of midkine in skeletal remodelling.

Liedert A, Schinke T, Ignatius A, Amling M.

Br J Pharmacol. 2014 Feb;171(4):870-8. doi: 10.1111/bph.12412. Review.

2.

Midkine: an emerging target of drug development for treatment of multiple diseases.

Muramatsu T, Kadomatsu K.

Br J Pharmacol. 2014 Feb;171(4):811-3. doi: 10.1111/bph.12571.

3.

Therapeutic potential of midkine in cardiovascular disease.

Kadomatsu K, Bencsik P, Görbe A, Csonka C, Sakamoto K, Kishida S, Ferdinandy P.

Br J Pharmacol. 2014 Feb;171(4):936-44. doi: 10.1111/bph.12537. Review.

4.

The midkine family of growth factors: diverse roles in nervous system formation and maintenance.

Winkler C, Yao S.

Br J Pharmacol. 2014 Feb;171(4):905-12. doi: 10.1111/bph.12462. Review.

5.

Increased trabecular bone formation in mice lacking the growth factor midkine.

Neunaber C, Catala-Lehnen P, Beil FT, Marshall RP, Kanbach V, Baranowsky A, Lehmann W, Streichert T, Ignatius A, Muramatsu T, Schinke T, Amling M.

J Bone Miner Res. 2010 Aug;25(8):1724-35. doi: 10.1002/jbmr.75.

6.

[The role of locally synthesized growth factors and cytokines in pathogenesis of osteoporosis].

Pindel B, Pluskiewicz W.

Chir Narzadow Ruchu Ortop Pol. 1996;61(5):487-91. Review. Polish.

PMID:
9026421
7.

Midkine-deficiency increases the anabolic response of cortical bone to mechanical loading.

Liedert A, Mattausch L, Röntgen V, Blakytny R, Vogele D, Pahl M, Bindl R, Neunaber C, Schinke T, Harroch S, Amling M, Ignatius A.

Bone. 2011 Apr 1;48(4):945-51. doi: 10.1016/j.bone.2010.12.019. Epub 2010 Dec 23.

PMID:
21185956
8.

[Regulation mechanisms of bone metabolism].

Fernandes MH.

Acta Med Port. 1998 Jan;11(1):41-52. Review. Portuguese.

9.

Dynamics of bone remodelling: biochemical and pathophysiological basis.

de Vernejoul MC.

Eur J Clin Chem Clin Biochem. 1996 Sep;34(9):729-34. Review.

PMID:
8891525
10.

[Bone metabolism: molecular mechanisms].

Neumann E, Schett G.

Z Rheumatol. 2007 Jul;66(4):286-9. Review. German.

PMID:
17562055
11.

[The physiopathology of osteoporosis: the role of local factors].

Girasole G, Giuliani N.

Ann Ital Med Int. 1995 Oct;10 Suppl:9S-17S. Review. Italian.

PMID:
8562275
12.

The osteoclast, bone remodelling and treatment of metabolic bone disease.

Boyce BF, Rosenberg E, de Papp AE, Duong LT.

Eur J Clin Invest. 2012 Dec;42(12):1332-41. doi: 10.1111/j.1365-2362.2012.02717.x. Epub 2012 Sep 23. Review.

PMID:
22998735
13.

Bone remodelling.

Meghji S.

Br Dent J. 1992 Mar 21;172(6):235-42. Review.

PMID:
1554530
14.

The expression and function of midkine in the vertebrate retina.

Gramage E, Li J, Hitchcock P.

Br J Pharmacol. 2014 Feb;171(4):913-23. doi: 10.1111/bph.12495. Review.

15.

Midkine in nephrogenesis, hypertension and kidney diseases.

Sato W, Sato Y.

Br J Pharmacol. 2014 Feb;171(4):879-87. doi: 10.1111/bph.12418. Review.

16.

Physiology and pathophysiology of bone remodeling.

Raisz LG.

Clin Chem. 1999 Aug;45(8 Pt 2):1353-8. Review. Erratum in: Clin Chem 1999 Oct;45(10):1885.

17.

Involvement of midkine in neuroblastoma tumourigenesis.

Kishida S, Kadomatsu K.

Br J Pharmacol. 2014 Feb;171(4):896-904. doi: 10.1111/bph.12442. Review.

18.

New mechanisms and targets in the treatment of bone fragility.

Martin TJ, Seeman E.

Clin Sci (Lond). 2007 Jan;112(2):77-91. Review.

PMID:
17155930
19.

Midkine as a regulator of B cell survival in health and disease.

Cohen S, Shachar I.

Br J Pharmacol. 2014 Feb;171(4):888-95. doi: 10.1111/bph.12419. Review.

20.

Bone remodeling.

Hadjidakis DJ, Androulakis II.

Ann N Y Acad Sci. 2006 Dec;1092:385-96. Review.

PMID:
17308163
Items per page

Supplemental Content

Write to the Help Desk